0001062993-21-002674.txt : 20210312
0001062993-21-002674.hdr.sgml : 20210312
20210312164054
ACCESSION NUMBER: 0001062993-21-002674
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210310
FILED AS OF DATE: 20210312
DATE AS OF CHANGE: 20210312
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Petrova Penka
CENTRAL INDEX KEY: 0001838044
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36596
FILM NUMBER: 21738079
MAIL ADDRESS:
STREET 1: C/O TRILLIUM THERAPEUTICS INC.
STREET 2: 2488 DUNWIN DRIVE
CITY: MISSISSAUGA
STATE: A6
ZIP: L5L 1J9
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Trillium Therapeutics Inc.
CENTRAL INDEX KEY: 0001616212
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: A6
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2488 DUNWIN DRIVE
CITY: MISSISSAUGA
STATE: A6
ZIP: L5L 1J9
BUSINESS PHONE: (416) 595-0627
MAIL ADDRESS:
STREET 1: 2488 DUNWIN DRIVE
CITY: MISSISSAUGA
STATE: A6
ZIP: L5L 1J9
4
1
form4.xml
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
X0306
4
2021-03-10
0001616212
Trillium Therapeutics Inc.
TRIL
0001838044
Petrova Penka
C/O TRILLIUM THERAPEUTICS INC.
2488 DUNWIN DRIVE
MISSISSAUGA
A6
L5L 1J9
ONTARIO, CANADA
0
1
0
0
Chief Development Officer
Common Shares
2021-03-10
4
M
0
2708
0.3012
A
2708
D
Common Shares
2021-03-10
4
M
0
2604
3.3524
A
5312
D
Common Shares
2021-03-10
4
S
0
5312
11.08
D
0
D
Stock Option (Right to Buy)
.3012
2021-03-10
4
M
0
2708
0
D
2029-11-07
Common Shares
2708
86668
D
Stock Option (Right to Buy)
3.3524
2021-03-10
4
M
0
2604
0
D
2028-11-08
Common Shares
2604
52084
D
This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person.
The exercise price of these options is $0.38 CAD and has been translated to USD in the table above at an exchange rate of $1.00 CAD to $0.7925 USD.
The exercise price of these options is $4.23 CAD and has been translated to USD in the table above at an exchange rate of $1.00 CAD to $0.7925 USD.
25% of the options vest on the one year anniversary of the grant date and the remaining options vest in equal monthly installments over the following 36 months.
/s/ James Parsons, Attorney-in-Fact
2021-03-12